These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10530589)

  • 1. Foodborne diseases: Shiga toxin producing E. coli (STEC).
    Bower JR
    Pediatr Infect Dis J; 1999 Oct; 18(10):909-10. PubMed ID: 10530589
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 3. Food poisoning cases must be handled with care.
    Lancet; 2005 Oct 15-21; 366(9494):1332. PubMed ID: 16226593
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview and Historical Perspectives.
    Kaper JB; O'Brien AD
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 25590020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterohaemorrhagic Escherichia coli.
    Takeda Y
    World Health Stat Q; 1997; 50(1-2):74-80. PubMed ID: 9282389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
    Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
    Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The occurrence of Shiga toxin-producing Escherichia coli in humans and animals].
    Heuvelink AE
    Tijdschr Diergeneeskd; 1999 Nov; 124(22):671-8. PubMed ID: 10596399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli O 157.
    CDR (Lond Engl Wkly); 1991 Oct; 1(43):195. PubMed ID: 1669885
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence profiling and quantification of verocytotoxin-producing Escherichia coli O145:H28 and O26:H11 isolated during an ice cream-related hemolytic uremic syndrome outbreak.
    Buvens G; Possé B; De Schrijver K; De Zutter L; Lauwers S; Piérard D
    Foodborne Pathog Dis; 2011 Mar; 8(3):421-6. PubMed ID: 21166561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
    Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
    Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome.
    Siegler RL
    JAMA; 2003 Sep; 290(10):1379-81. PubMed ID: 12966132
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
    Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
    Nelson JM; Griffin PM; Jones TF; Smith KE; Scallan E
    Clin Infect Dis; 2011 May; 52(9):1130-2. PubMed ID: 21467017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
    Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
    J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues.
    Karmali MA
    J Infect Dis; 2004 Feb; 189(3):355-9. PubMed ID: 14745691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.